HIGHLIGHTS
- who: Camille Winnicki et al. from the Department of Pediatric Immunology, Hematology and Oncology, Children Hospital of La Timone, Assistance Publique Hu00f4pitaux Marseille, Marseille, France Department of Pediatric Immunohematology and Oncology, University Hospital, Grenoble, France have published the Article: Retrospective National u201cReal Lifeu201d Experience of the SFCE with the Metronomic MEMMAT and MEMMAT-like Protocol, in the Journal: (JOURNAL)
- what: Our series confirms the capacity of the MEMMAT regimen to control relapsing/refractory pediatric brain malignancies beyond medulloblastomas.
SUMMARY
Indeed, whenIndeed, patients received MEMMAT a second as line of treatment, on . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.